2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$32.97-$0.44 (-1.33%)
Price as of Jun 23, 2026 6:30 PM EDT- $2.6BMarket Cap
- 63.85%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$32.97-$0.44 (-1.33%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.41 | ||
Change | +$0.98 (+3.02%) | ||
Open | $32.90 | ||
High | $33.46 | ||
Low | $32.26 | ||
Previous Close | $32.43 | ||
Volume | 1,957,840 | ||
30-Day Average Volume | 934,799 | ||
1-Week Change | 4.02% | ||
1-Month Change | 8.72% | ||
1-Year Change | 63.85% | ||
3-Year Change | -8.62% | ||
5-Year Change | 16.21% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $511.3M | ||
Market Cap | $2.6B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $15,000.00 | ||
Net Income | -$78.7M | ||
Free Cash Flow | -$67.2M | ||
EBIT | -$78.7M | ||
EBITDA | -$77.8M | ||
Net Working Capital | $407.8M | ||
EPS | -$1.18 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 172,446 | ||
P/B | 6 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue